Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...

The so-called 'hybrid closed-loop' system comprises a blood glucose sensor, the MiniMed 670G insulin pump and an infusion patch. Type 1 diabetes patients using the device will no longer have to ...

Insulin pump therapy, also known as continuous subcutaneous ... A.L.P. has been a consultant for Medtronic MiniMed and has received a grant from the Medtronic/MiniMed Foundation.

Roche is teaming up with two medical tech companies to develop an automated insulin delivery system, the first steps towards an ‘artificial pancreas.’ The Swiss pharma will work with existing ...

The CONTOUR Link wirelessly transmits blood glucose test results to compatible Medtronic insulin pumps and continuous glucose monitoring systems making insulin dosing easier than ever.

Medtronic is a solid dividend-paying stock. Its stock recently yielded 3.2%. It has increased its payout for nearly 50 years in a row. If you're a dividend investor, I can understand why ...

Hybrid closed-loop systems outperformed other types of subcutaneous insulin treatment for diabetes, but some systems were more efficient than others, according to results published in ...

One of the significant advancements in diabetes management is the use of insulin pump therapy, which provides a continuous supply of insulin to help maintain stable blood glucose levels.

The CDC’s primary medical journal for disseminating public health information went unpublished this week — seemingly for the first time ever — amid a communications freeze issued by HHS to ...

After hours: January 24 at 4:09:44 PM EST ...

Pre-market: 6:19:53 am GMT-5 ...